Spectrum Antimicrobials is dedicated to combating infectious diseases and eradicating antibiotic-resistant and multi-drug resistant pathogens. With a focus on global healthcare, the brand offers a range of products and services designed to prevent and treat infections. Their scientific expertise in microbiology, chemistry, and toxicology has allowed them to create formulation chemistries that effectively eliminate infectious agents and reduce topical pain and itchiness while promoting accelerated wound healing.

Their proprietary antiviral and antimicrobial platforms are highly effective against bacteria, including antibiotic-resistant strains, viruses, fungi, mold, and spores on various surfaces. Importantly, these platforms do not contribute to the emergence of additional resistant pathogens. Spectrum Antimicrobials goes beyond treatment by developing innovative health solutions that aim to prevent infections and potentially redefine the standard of care.

Their products are designed for various medical settings, including surgical sites, invasive surgeries, burn and wound care, dermatology, ophthalmology, and medical device usage. Led by CEO and Founder Hoji Alimi, the team at Spectrum Antimicrobials is committed to improving patient lives through first-in-class, innovative anti-infective chemistries. To learn more about investing in Spectrum Antimicrobials, visit their website